Dr. David Burstein, M.D.
Nephrology (Kidney) (Nephrology Physician)
7301 E 2nd St, Suite 118
Scottsdale, AZ 85251
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 791
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: University of Minnesota Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
AZ license 35580
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Honorhealth Scottsdale Shea Medical Center Scottsdale, AZ
- Honorhealth Scottsdale Osborn Medical Center Scottsdale, AZ
- Honorhealth Scottsdale Thompson Peak Med Ctr Scottsdale, AZ
- Abrazo Scottsdale Campus Phoenix, AZ
Medical groups
- Akdhc LLC (129 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 791
- Services billed
- 5,627
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,700 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 669 | 247 |
| Established patient office or other outpatient visit, 30-39 minutes | 573 | 382 |
| Established patient office or other outpatient visit, 40-54 minutes | 393 | 229 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 150 | 137 |
| Injection of drug or substance under skin or into muscle | 91 | 37 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 91 | 17 |
| New patient office or other outpatient visit, 60-74 minutes | 60 | 60 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | 17 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 22 payments worth $404 in total to this clinician.
| Amgen Inc. | $108 |
|---|---|
| Daiichi Sankyo Inc. | $107 |
| Otsuka America Pharmaceutical, Inc. | $46.80 |
| Novo Nordisk Inc | $34.79 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $27.38 |
| Calliditas Therapeutics US Inc. | $21.01 |
| Opko Pharmaceuticals, LLC | $19.56 |
| Ardelyx, Inc. | $18.15 |
| Food and Beverage | $381 |
|---|---|
| Education | $23.27 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Opko Pharmaceuticals, LLC Dec 8, 2025 | Education RAYALDEE · NEPHROLOGY · in-kind | $19.56 |
| Travere Therapeutics, Inc. May 12, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Nov 19, 2025 | Education Filspari · Kidney Disease · in-kind | $1.66 |
| Travere Therapeutics, Inc. Nov 19, 2025 | Education Filspari · Kidney Disease · in-kind | $0.39 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.